JP2007106688A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007106688A5 JP2007106688A5 JP2005297991A JP2005297991A JP2007106688A5 JP 2007106688 A5 JP2007106688 A5 JP 2007106688A5 JP 2005297991 A JP2005297991 A JP 2005297991A JP 2005297991 A JP2005297991 A JP 2005297991A JP 2007106688 A5 JP2007106688 A5 JP 2007106688A5
- Authority
- JP
- Japan
- Prior art keywords
- cytokine
- related gene
- units
- expression inhibitor
- weight hyaluronan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000695 Cytokines Proteins 0.000 claims 6
- 102000004127 Cytokines Human genes 0.000 claims 6
- 108090000623 proteins and genes Proteins 0.000 claims 5
- 229940122498 Gene expression inhibitor Drugs 0.000 claims 4
- 239000003795 chemical substances by application Substances 0.000 claims 4
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 claims 4
- 229940099552 hyaluronan Drugs 0.000 claims 4
- 229920002674 hyaluronan Polymers 0.000 claims 4
- 102000019034 Chemokines Human genes 0.000 claims 3
- 108010012236 Chemokines Proteins 0.000 claims 3
- 230000014509 gene expression Effects 0.000 claims 3
- 239000004480 active ingredient Substances 0.000 claims 2
- 238000002347 injection Methods 0.000 claims 2
- 239000007924 injection Substances 0.000 claims 2
- 235000000346 sugar Nutrition 0.000 claims 2
- 150000008163 sugars Chemical class 0.000 claims 2
- 150000004044 tetrasaccharides Chemical class 0.000 claims 2
- 230000002757 inflammatory effect Effects 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
Priority Applications (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005297991A JP2007106688A (ja) | 2005-10-12 | 2005-10-12 | サイトカイン関連遺伝子及びケモカイン関連遺伝子の発現抑制剤 |
| US11/438,819 US20070099867A1 (en) | 2005-05-24 | 2006-05-23 | Pharmaceutical agent containing hyaluronan as an active ingredient |
| AU2006220353A AU2006220353A1 (en) | 2005-05-24 | 2006-09-20 | Pharmaceutical Agent Containing Hyaluronan as an Active Ingredient |
| NO20064337A NO20064337L (no) | 2005-09-26 | 2006-09-25 | Farmasoytisk middel inneholdende hyaluronan som en aktiv ingrediens |
| RU2006134169/15A RU2342148C2 (ru) | 2005-09-26 | 2006-09-25 | Фармацевтическое средство, содержащее гиалуронан в качестве активного ингредиента |
| CA2560844A CA2560844C (en) | 2005-09-26 | 2006-09-25 | Pharmaceutical agent containing hyaluronan as an active ingredient |
| EP06020126A EP1767211B1 (en) | 2005-09-26 | 2006-09-26 | Pharmaceutical agent containing hyaluronan as an active ingredient |
| AT06020126T ATE552005T1 (de) | 2005-09-26 | 2006-09-26 | Pharmazeutische zusammensetzung hyaluronan als aktive komponente enthaltend |
| BRMU8603015-9U BRMU8603015U (pt) | 2005-09-26 | 2006-09-26 | agente farmacêutico contendo hialuronano como componente ativo |
| ARP060104194A AR056091A1 (es) | 2005-09-26 | 2006-09-26 | Agente farmaceutico que contiene hialuronano como ingrediente activo |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005297991A JP2007106688A (ja) | 2005-10-12 | 2005-10-12 | サイトカイン関連遺伝子及びケモカイン関連遺伝子の発現抑制剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007106688A JP2007106688A (ja) | 2007-04-26 |
| JP2007106688A5 true JP2007106688A5 (cg-RX-API-DMAC7.html) | 2007-11-29 |
Family
ID=38032837
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005297991A Pending JP2007106688A (ja) | 2005-05-24 | 2005-10-12 | サイトカイン関連遺伝子及びケモカイン関連遺伝子の発現抑制剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2007106688A (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014138897A1 (en) * | 2013-03-14 | 2014-09-18 | Anacoti Ltd. | Hyaluronic acid derivatives |
-
2005
- 2005-10-12 JP JP2005297991A patent/JP2007106688A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008513467A5 (cg-RX-API-DMAC7.html) | ||
| ECSP088239A (es) | Composición de liberación de fármaco sostenida | |
| JP2010047612A5 (cg-RX-API-DMAC7.html) | ||
| JP2012530141A5 (cg-RX-API-DMAC7.html) | ||
| JP2010514554A5 (cg-RX-API-DMAC7.html) | ||
| MX351104B (es) | Nuevos glucosaminoglucanos con baja actividad anticoagulante. | |
| EA200970081A1 (ru) | Соединения, обладающие потенциирующим действием в отношении активности этионамида, и их применения | |
| NO20074872L (no) | Pyrazoler | |
| WO2006044421A3 (en) | Cardiac safe, rapid medication delivery | |
| NO20084253L (no) | Tetrahydroisokinolinderivater for a forbedre hukommelsesfunksjon | |
| WO2010017215A3 (en) | Biodegradable microspheres and methods of use thereof | |
| NZ608239A (en) | Aqueous drug delivery system comprising off - flavor masking agent | |
| JP2010508499A5 (cg-RX-API-DMAC7.html) | ||
| EP2279726A3 (en) | Compositions and methods using same for delivering agents into a target organ protected by a blood barrier | |
| JP2004525917A5 (cg-RX-API-DMAC7.html) | ||
| JP2007106688A5 (cg-RX-API-DMAC7.html) | ||
| JP2009155453A5 (cg-RX-API-DMAC7.html) | ||
| JP2009516719A5 (cg-RX-API-DMAC7.html) | ||
| TW200716616A (en) | Modulators of CCR-5 activity | |
| ATE553755T1 (de) | Stärke enthaltende beschichtungszusammensetzung | |
| JP2006335694A5 (cg-RX-API-DMAC7.html) | ||
| JP2006522806A5 (cg-RX-API-DMAC7.html) | ||
| NO20073850L (no) | Farmasoytisk polymersammensetning for oral kontrollert frigivelsesavlevering av terbutalinsulfat | |
| EP1847244A4 (en) | METABOLISM SYNDROME IMPROVING AGING AND MEDICINE, ADDITIVE, FUNCTIONAL FOOD AND ADDITIVE FOOD ADDITIVE | |
| DE112005002932A5 (de) | Pharmazeutischer Wirkstoff gegen das HIV-Syndrom |